PDS Biotechnology Corp SEC filings PDSB
PDS Biotechnology Corp has 795 filings in SEC EDGAR's recent list, going back to Sep 16, 2009. Its latest annual report, Form ARS, was filed on Jun 26, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 21, 2026 (other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Jul 21, 2026 | — |
| EFFECT | Filing | Apr 28, 2026 | — |
| CORRESP | Letter to the SEC | Apr 24, 2026 | — |
| UPLOAD | Letter from the SEC | Sep 4, 2025 | — |
| EFFECT | Filing | Jun 10, 2025 | — |
| CORRESP | Letter to the SEC | Jun 6, 2025 | — |
| UPLOAD | Letter from the SEC | May 30, 2025 | — |
| DEFR14A | Filing | May 22, 2025 | — |
| DEFR14A | Filing | May 5, 2025 | — |
| EFFECT | Filing | Sep 2, 2022 | — |
| CORRESP | Letter to the SEC | Aug 30, 2022 | — |
| UPLOAD | Letter from the SEC | Aug 29, 2022 | — |
| EFFECT | Filing | Jul 31, 2020 | — |
| CORRESP | Letter to the SEC | Jul 29, 2020 | — |
| UPLOAD | Letter from the SEC | Jul 27, 2020 | — |
| EFFECT | Filing | Feb 11, 2020 | — |
| CORRESP | Letter to the SEC | Feb 10, 2020 | — |
| CORRESP | Letter to the SEC | Feb 10, 2020 | — |
| CORRESP | Letter to the SEC | Feb 7, 2020 | — |
| CORRESP | Letter to the SEC | Feb 7, 2020 | — |
| CORRESP | Letter to the SEC | Feb 6, 2020 | — |
| CORRESP | Letter to the SEC | Feb 6, 2020 | — |
| CORRESP | Letter to the SEC | Feb 5, 2020 | — |
| CORRESP | Letter to the SEC | Feb 5, 2020 | — |
| CORRESP | Letter to the SEC | Feb 4, 2020 | — |
| CORRESP | Letter to the SEC | Feb 4, 2020 | — |
| CORRESP | Letter to the SEC | Jan 31, 2020 | — |
| CORRESP | Letter to the SEC | Jan 31, 2020 | — |
| UPLOAD | Letter from the SEC | Dec 23, 2019 | — |
| EFFECT | Filing | Aug 28, 2019 | — |
| CORRESP | Letter to the SEC | Aug 26, 2019 | — |
| CORRESP | Letter to the SEC | Aug 20, 2019 | — |
| UPLOAD | Letter from the SEC | Aug 14, 2019 | — |
| 425 | Filing | Mar 4, 2019 | — |
| 425 | Filing | Mar 4, 2019 | — |
| 425 | Filing | Feb 25, 2019 | — |
| 425 | Filing | Feb 21, 2019 | — |
| CT ORDER | Filing | Feb 15, 2019 | — |
| 425 | Form 8-k | Feb 4, 2019 | — |
| 425 | Form 8-k | Jan 30, 2019 | — |
| 425 | 8-k | Nov 26, 2018 | — |
| CT ORDER | Filing | Sep 1, 2017 | — |
| EFFECT | Filing | Nov 2, 2016 | — |
| UPLOAD | Letter from the SEC | Nov 1, 2016 | — |
| CORRESP | Letter to the SEC | Nov 1, 2016 | — |
| CT ORDER | Filing | Apr 27, 2016 | — |
| CT ORDER | Filing | Dec 17, 2015 | — |
| EFFECT | Filing | Sep 30, 2015 | — |
| CERTNAS | Auto-generated paper document | Sep 30, 2015 | — |
| CORRESP | Letter to the SEC | Sep 28, 2015 | — |
| CORRESP | Letter to the SEC | Sep 28, 2015 | — |
| 8-A12B | Form 8-a12b | Sep 25, 2015 | — |
| CORRESP | Letter to the SEC | Sep 14, 2015 | — |
| CORRESP | Letter to the SEC | Aug 14, 2015 | — |
| UPLOAD | Letter from the SEC | Jun 10, 2015 | — |
| DRSLTR | Filing | May 20, 2015 | — |
| DRS/A | Filing | May 20, 2015 | — |
| D | Filing | Apr 9, 2015 | — |
| UPLOAD | Letter from the SEC | Dec 18, 2014 | — |
| DRSLTR | Filing | Dec 4, 2014 | — |
| DRS/A | Filing | Dec 4, 2014 | — |
| D | Filing | Nov 13, 2014 | — |
| UPLOAD | Letter from the SEC | Sep 26, 2014 | — |
| DRS/A | Filing | Sep 10, 2014 | — |
| DRSLTR | Filing | Jul 10, 2014 | — |
| DRS/A | Filing | Jul 10, 2014 | — |
| UPLOAD | Letter from the SEC | Jun 6, 2014 | — |
| DRSLTR | Filing | May 19, 2014 | — |
| DRS/A | Filing | May 19, 2014 | — |
| UPLOAD | Letter from the SEC | Apr 18, 2014 | — |
| DRS | Filing | Mar 21, 2014 | — |
| D | Filing | Mar 25, 2013 | — |
| D | Filing | Sep 17, 2012 | — |
| D | Filing | Jun 24, 2011 | — |
| D/A | Filing | Nov 8, 2010 | — |
| D | Filing | Sep 16, 2009 | — |
Showing 76 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- PDSB (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Princeton, NJ
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1472091
- Former names
- Edge Therapeutics, Inc. (until Mar 18, 2019)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.